Annual EBITDA
$1.14B$163.30M-12.57%
Summary
- Current Value
- As of today, AVTR annual EBITDA is $1.14B, down -12.57% on
- Historical Performance
- AVTR annual EBITDA is down -21.70% over the past 3 years, and up +16.48% over the past 5 years
- All-Time High Comparison
- AVTR annual EBITDA is currently -27.12% below its historical high of $1.56B set on
- 3-Year Low Comparison
- AVTR annual EBITDA is at its 3-year low
- Sector Comparison
- AVTR annual EBITDA is higher than 94.15% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.14B | -12.6% | -21.7% | +16.5% | +838.6% | |
| Quarterly EBITDA | $242.90M | -12.1% | -35.7% | -12.8% | +214.8% | |
| TTM EBITDA | $1.04B | -7.9% | -33.5% | -1.4% | +592.2% | |
| Price | $12.26 | -44.6% | -40.7% | -57.7% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $6.78B | -2.6% | -8.2% | +12.3% | +965.1% | |
| Annual EPS | $1.04 | +120.5% | +23.2% | +224.9% | +2482.7% | |
| Annual EBIT | $730.20M | -18.6% | -31.8% | +26.8% | +1111.0% | |
| Annual Net Income | $711.50M | +121.6% | +24.3% | +1782.3% | +5502.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.56B | N/A | -27.1% |
| 5Y | $1.56B | -27.1% | |
| All | $1.56B | -27.1% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.14B | at low | |
| 5Y | $1.11B | N/A | +1.9% |
| All | $84.70M | +1240.8% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $1.14B | -12.6% | |
| $1.30B | -16.6% | |
| $1.56B | +7.4% | |
| $1.45B | +30.2% | |
| $1.11B | +14.3% |
| Year | Value | Change |
|---|---|---|
| $975.00M | +6.7% | |
| $913.90M | +979.0% | |
| $84.70M | -13.3% | |
| $97.70M | -19.3% | |
| $121.00M | - |
FAQ
What is the current annual EBITDA of AVTR?
As of today, AVTR annual EBITDA is $1.14B
What is 1-year change in AVTR annual EBITDA?
AVTR annual EBITDA is down -12.57% year-over-year
What is 3-year change in AVTR annual EBITDA?
AVTR annual EBITDA is down -21.70% over the past 3 years
How far is AVTR annual EBITDA from its all-time high?
AVTR annual EBITDA is currently -27.12% below its historical high of $1.56B set on December 31, 2022
How does AVTR annual EBITDA rank versus sector peers?
AVTR annual EBITDA is higher than 94.15% of companies in Healthcare sector
When is AVTR next annual earnings release?
The next annual earnings release for AVTR is on
Quarterly EBITDA
$242.90M$10.00M-3.95%
Summary
- Current Value
- As of today, AVTR quarterly EBITDA is $242.90M, down -3.95% on
- Historical Performance
- AVTR quarterly EBITDA is down -12.12% year-over-year, and down -35.69% over the past 3 years
- All-Time High Comparison
- AVTR quarterly EBITDA is currently -42.63% below its historical high of $423.40M set on
- 3-Year Low Comparison
- AVTR quarterly EBITDA is at its 3-year low
- Sector Comparison
- AVTR quarterly EBITDA is higher than 92.86% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $242.90M | -4.0% | -12.1% | -35.7% | -12.8% | |
| Annual EBITDA | $1.14B | – | -12.6% | -21.7% | +16.5% | |
| TTM EBITDA | $1.04B | -3.1% | -7.9% | -33.5% | -1.4% | |
| Price | $12.26 | -9.4% | -44.6% | -40.7% | -57.7% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $1.62B | -3.5% | -5.3% | -12.5% | +1.2% | |
| Quarterly EPS | -$1.04 | -1200.3% | -1334.3% | -524.8% | -933.9% | |
| Quarterly EBIT | $138.40M | -7.9% | -20.5% | -50.0% | -22.9% | |
| Quarterly Net Income | -$711.80M | -1200.2% | -1331.5% | -526.2% | -1586.7% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $294.20M | N/A | -17.4% |
| 3Y | $357.90M | N/A | -32.1% |
| 5Y | $423.40M | -42.6% | |
| All | $423.40M | -42.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $242.90M | at low | |
| 3Y | $242.90M | at low | |
| 5Y | $242.90M | at low | |
| All | -$211.60M | +214.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of AVTR?
As of today, AVTR quarterly EBITDA is $242.90M
What is AVTR quarterly EBITDA most recent change?
AVTR quarterly EBITDA was down -3.95% on September 30, 2025
What is 1-year change in AVTR quarterly EBITDA?
AVTR quarterly EBITDA is down -12.12% year-over-year
How far is AVTR quarterly EBITDA from its all-time high?
AVTR quarterly EBITDA is currently -42.63% below its historical high of $423.40M set on March 31, 2022
How does AVTR quarterly EBITDA rank versus sector peers?
AVTR quarterly EBITDA is higher than 92.86% of companies in Healthcare sector
When is AVTR next earnings release?
The next earnings release for AVTR is on
TTM EBITDA
$1.04B$33.50M-3.12%
Summary
- Current Value
- As of today, AVTR TTM EBITDA is $1.04B, down -3.12% on
- Historical Performance
- AVTR TTM EBITDA is down -7.89% year-over-year, and down -33.48% over the past 3 years
- All-Time High Comparison
- AVTR TTM EBITDA is currently -33.48% below its historical high of $1.57B set on
- 3-Year Low Comparison
- AVTR TTM EBITDA is at its 3-year low
- Sector Comparison
- AVTR TTM EBITDA is higher than 93.41% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.04B | -3.1% | -7.9% | -33.5% | -1.4% | |
| Annual EBITDA | $1.14B | – | -12.6% | -21.7% | +16.5% | |
| Quarterly EBITDA | $242.90M | -4.0% | -12.1% | -35.7% | -12.8% | |
| Price | $12.26 | -9.4% | -44.6% | -40.7% | -57.7% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $6.58B | -1.4% | -3.6% | -13.8% | +7.3% | |
| TTM EPS | -$0.12 | -112.1% | -126.8% | -113.7% | -200.3% | |
| TTM EBIT | $633.70M | -5.3% | -12.7% | -45.2% | -4.8% | |
| TTM Net Income | -$82.20M | -112.0% | -126.5% | -112.9% | -160.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.13B | N/A | -7.7% |
| 3Y | $1.54B | N/A | -32.6% |
| 5Y | $1.57B | -33.5% | |
| All | $1.57B | -33.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.04B | at low | |
| 3Y | $1.04B | at low | |
| 5Y | $1.04B | at low | |
| All | -$211.60M | +592.2% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of AVTR?
As of today, AVTR TTM EBITDA is $1.04B
What is AVTR TTM EBITDA most recent change?
AVTR TTM EBITDA was down -3.12% on September 30, 2025
What is 1-year change in AVTR TTM EBITDA?
AVTR TTM EBITDA is down -7.89% year-over-year
How far is AVTR TTM EBITDA from its all-time high?
AVTR TTM EBITDA is currently -33.48% below its historical high of $1.57B set on September 30, 2022
How does AVTR TTM EBITDA rank versus sector peers?
AVTR TTM EBITDA is higher than 93.41% of companies in Healthcare sector
When is AVTR next earnings release?
The next earnings release for AVTR is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- AVTR Official Website www.avantorsciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1722482/000162828025046936/0001628280-25-046936-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1722482/000172248225000015/0001722482-25-000015-index.htm
- AVTR Profile on Yahoo Finance finance.yahoo.com/quote/AVTR
- AVTR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/avtr